Korro Bio, Inc. (KRRO) stock
KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.44+0.12 (+0.97%)
Close on Nov 18, 2026Market cap $183.19MP/E –Yield –
Korro Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Korro Bio's free cash flow for the twelve months ending Jun 30, 2026 was -$68.27M. For fiscal 2025 it was -$79.08M. The highest annual figure on record is $33.15M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$79.08M | – |
| FY2024 | Dec 31, 2024 | -$77.98M | – |
| FY2023 | Dec 31, 2023 | -$75.12M | – |
| FY2022 | Dec 31, 2022 | -$58.78M | – |
| FY2021 | Dec 31, 2021 | -$78.97M | – |
| FY2020 | Dec 31, 2020 | -$51.86M | -256.4% |
| FY2019 | Dec 31, 2019 | $33.15M | – |
| FY2018 | Dec 31, 2018 | -$17.46M | – |
| FY2017 | Dec 31, 2017 | -$16.48M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.03M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.79M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.35M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$24.57M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.95M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.97M | – |
| Q2 FY2024 | Jun 30, 2024 | -$20.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$27.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.76M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.14M | – |
| Q1 FY2023 | Mar 31, 2023 | -$21.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.36M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.95M | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.33M | – |
| Q2 FY2021 | Jun 30, 2021 | -$19.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$19.25M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.73M | -115.8% |
| Q2 FY2020 | Jun 30, 2020 | -$11.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$30.16M | – |
| Q3 FY2019 | Sep 30, 2019 | $74.43M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.50M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.61M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.96M | – |
See a number that looks wrong?